Exhibit 107
Calculation of Filing Fee Tables
S-8
Immunome, Inc.
Table 1: Newly Registered Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Security Type |
|
Security Class Title |
|
Fee Calculation Rule |
|
Amount Registered |
|
|
Proposed Maximum Offering Price Per Unit |
|
|
Maximum Aggregate Offering Price |
|
Fee Rate |
|
|
Amount of Registration Fee |
1 |
|
Equity |
|
2020 Equity Incentive Plan, Common Stock, $0.0001 par value per share |
|
Other |
|
4,525,327 |
|
$ |
22.39 |
|
$ |
101,322,071.53 |
|
0.0001381 |
|
$ |
13,992.58 |
2 |
|
Equity |
|
2024 Inducement Plan, Common Stock, $0.0001 par value per share |
|
Other |
|
1,500,000 |
|
$ |
22.39 |
|
$ |
33,585,000.00 |
|
0.0001381 |
|
$ |
4,638.09 |
3 |
|
Equity |
|
2020 Employee Stock Purchase Plan, Common Stock, $0.0001 par value per share |
|
Other |
|
1,000,000 |
|
$ |
19.03 |
|
$ |
19,030,000.00 |
|
0.0001381 |
|
$ |
2,628.04 |
Total Offering Amounts: |
|
|
|
|
$ |
153,937,071.53 |
|
|
|
$ |
21,258.71 |
Total Fee Offsets: |
|
|
|
|
|
|
|
|
|
$ |
0.00 |
Net Fee Due: |
|
|
|
|
|
|
|
|
|
$ |
21,258.71 |
Offering Note |
|
|
|
|
|
|
|
|
|
|
|
|
|
1.Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover additional shares of Common Stock, $0.0001 par value per share (“Common Stock”), of Immunome, Inc. (the “Registrant”) that become issuable under the Registrant’s 2020 Equity Incentive Plan (the “2020 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction. The amount registered represents additional shares of Common Stock reserved for future grant under the 2020 Plan as a result of the automatic increase in shares reserved thereunder on January 1, 2026 pursuant to the terms of the 2020 Plan. The 2020 Plan provides that an additional number of shares will automatically be added annually to the shares authorized for issuance under the 2020 Plan on January 1 of each calendar year through (and including) January 1, 2030, in an amount equal to the lesser of (a) 4% of the total number of shares of capital stock of the Registrant outstanding on December 31st of the preceding calendar year; or (b) a lesser number of shares of Common Stock as the Registrant’s board of directors (the “Board”) may designate no later than December 31st of the immediately preceding year. The proposed maximum offering price per unit and maximum aggregate offering price are estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) of the Securities Act using the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Capital Market on February 24, 2026.